The FDA joins the VPHi-Alliance Research WG

The FDA will actively collaborate on the activities of the Research WG

We are happy to announce that following the signing of the memorandum of understanding (MoU) between the Alliance and the FDA, the FDA staff members will contribute to the VPHi- Avicenna Alliance Research WG. 

The MoU was signed back in May this year to seal the successful collaboration between the Alliance and the FDA, an formalise the willingness of both organisations to continue to guide and help each other in the next months and years.

We look forward to this new exciting collaboration!

The group composed by over 30 members from both industry and academia focuses on the promotion of in silico medicine research, acting as a consultative group that provides technical/detailed scientific inputs into health policy.

The activities of the WG are open to all VPHi and Avicenna members. In case you're interested to join please contact the VPHi manager.

Further information on the MoU can be found here.


Date: 06/11/2017 | Tag: | News: 685 of 689
All news

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Are you...

A clinician?
A researcher?
A science curious?
An industrial?

Open subscribe Reduce

ARCHIVE

Read all the newsletters of the VPH Institute

GO